Indivior Pharmaceuticals Inc (INDV)
NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$36.37
▼ -2.68%
Market Cap
$4.54B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.14
52-Wk Range
21.16-42.81
CEO
Joseph J. Ciaffoni
Country
US
Currency
USD
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Open full interactive analysis & DCF →